The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

TAIPEI, Taiwan (AP) — China has given broader approval for the domestic-made Sinovac coronavirus vaccine, expanding those who can receive it beyond the high-risk and priority groups already allowed ...

Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled ...

KINSHASA - The Democratic Republic of the Congo (DRC) on Wednesday received a batch of Chinese Sinovac COVID-19 vaccines ...

BEIJING, Aug 28 (Reuters) - Sinovac Biotech Ltd's (SVA.O), opens new tab coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk ...

SAO PAULO, Nov 19 (Reuters) - The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech (SVA.O), opens new tab that is being tested in Brazil, arrived at São ...

Many countries are betting on a vaccine from China to help them stop the coronavirus — although questions are surfacing about whether it's a smart bet. The vaccine is made by the Chinese ...

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the ...

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.